Announcements
Sidley Represents Capricor Therapeutics in Common Stock Offering
October 24, 2024
Sidley represented Capricor Therapeutics, Inc. in connection with an underwritten public offering of 5,073,800 shares of its common stock, including the exercise in full of the underwriters’ option to purchase additional shares to cover overallotments, bringing the total gross proceeds to Capricor from the offering to approximately US$86.3 million. Piper Sandler & Co. and Oppenheimer & Co. Inc. acted as the joint book-running managers for the offering.
The deal team was led by Rob Carlson and included Nick DeAngelis and Nithya Swaminathan.
Contacts
Capabilities
Suggested News & Insights
Sidley Represents HealthCare Royalty in Monetization Agreement for Modeyso Commercial RoyaltiesApril 24, 2026Sidley Represents Underwriters in Connection With National Healthcare Properties’ US$462 Million Public OfferingApril 23, 2026Sidley Represents Liberty Mutual in US$750 Million Senior Notes OfferingApril 23, 2026Sidley Represents Cboe Global Markets in Its US$300 Million Sale of Cboe Australia and Cboe Canada to TMX GroupApril 22, 2026Sonia Gupta Barros to Speak at PLI’s 2026 Global Capital Markets & the U.S. Securities Laws ProgramTuesday, April 21, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory